Tissue oxidative metabolism after extreme hemodilution with PEG-conjugated hemoglobin.
NADH-localized fluorometry was used as a noninvasive technique to monitor changes in the energy state of intact tissue (muscle and connective tissue), without anesthesia, as a function of blood plasma O(2)-carrying capacity in the hamster window chamber model. Acute moderate isovolemic hemodilution was induced by two isovolemic hemodilution steps: in the first step, 6% 70-kDa dextran (Dex70) was used to induce an acute anemic state (18% Hct); in the second step, exchange transfusion of polyethylene glycol (PEG) maleimide-conjugated Hb (4 g/dl, PEG-Hb) or Dex70 (6 g/dl) was used to reduce erythrocytes to 75% of baseline (11% Hct). PEG-Hb had six copies of PEG (5 kDa) conjugated to each human Hb (0.48 g PEG/g Hb) through extension arm-facilitated chemistry. Systemic parameters, microvascular perfusion, functional capillary density, intravascular and interstitial Po(2), and intracellular NADH fluorescence were monitored. Mean arterial blood pressure after extreme hemodilution was statistically significantly reduced for Dex70 compared with PEG-Hb. The presence of PEG-Hb in the circulation maintained positive acid-base balance. While microvascular blood flows were not different, functional capillary density was significantly higher for PEG-Hb than Dex70. Arteriolar Po(2) was higher in the presence of PEG-Hb than Dex70, but tissue and venular Po(2) were not different. Cellular energy metabolism (intracellular O(2)) in the tissues was improved with PEG-Hb. Moderate hemodilution to 18% Hct (6.4 g Hb/dl) brings tissue O(2) delivery to the verge of inadequacy. Extreme hemodilution to 11% Hct (3.7 g Hb/dl) produces tissue anoxia, and high-O(2)-affinity PEG-Hb (Po(2) at which blood is 50% saturated with O(2) = 4 Torr, 1.1 g Hb/dl) only partially decreases anaerobic metabolism without increasing tissue Po(2).
Cabrales
Pedro
P
Department of Bioengineering, University of California, San Diego, 9500 Gilman Dr., La Jolla, CA 92093-0412, USA. pcabrales@ucsd.edu
Meng
Fantao
F
Acharya
Seetharama A
SA
D000136:Acid-Base Equilibrium / Q000187:drug effects; D000740:Anemia / Q000097:blood / Q000139:chemically induced* / Q000503:physiopathology; D000818:Animals; D001802:Blood Substitutes / Q000633:toxicity*; D003238:Connective Tissue / Q000098:blood supply / Q000187:drug effects* / Q000378:metabolism; D006224:Cricetinae; D005470:Fluorometry; D006438:Hemodilution / Q000009:adverse effects*; D006439:Hemodynamics / Q000187:drug effects; D006454:Hemoglobins / Q000633:toxicity*; D000860:Hypoxia / Q000097:blood / Q000139:chemically induced* / Q000503:physiopathology; D008297:Male; D008301:Maleimides / Q000633:toxicity*; D008647:Mesocricetus; D008833:Microcirculation / Q000187:drug effects; D009132:Muscles / Q000098:blood supply / Q000187:drug effects* / Q000378:metabolism; D009243:NAD / Q000378:metabolism; D010100:Oxygen / Q000097:blood*; D011092:Polyethylene Glycols / Q000633:toxicity*; D013997:Time Factors
D001802:Blood Substitutes; D006454:Hemoglobins; D008301:Maleimides; C493836:maleimide-polyethylene glycol-modified hemoglobin, MP4; D009243:NAD; D011092:Polyethylene Glycols; D010100:Oxygen
Ann Biomed Eng. 1996 Jan-Feb;24(1):1-24
8669708
Artif Organs. 2004 Sep;28(9):800-6
15320943
Am J Physiol Heart Circ Physiol. 2005 May;288(5):H2146-53
15637119
Microvasc Res. 1973 May;5(3):309-12
4709728
Curr Hematol Rep. 2003 Nov;2(6):503-10
14561395
Am J Physiol. 1999 Nov;277(5):H1831-40
10564137
Biophys J. 1989 Apr;55(4):621-30
2720061
Am J Physiol Heart Circ Physiol. 2004 Jul;287(1):H320-30
15210452
Artif Cells Blood Substit Immobil Biotechnol. 2008;36(6):499-512
19085194
Microvasc Res. 2003 Jan;65(1):32-8
12535869
Transfusion. 1995 Jul;35(7):559-65
7631387
Pharmacol Rev. 1991 Jun;43(2):109-42
1852778
Transfusion. 2003 Apr;43(4):509-16
12662285
World J Surg. 1996 Nov-Dec;20(9):1208-17
8864083
Free Radic Biol Med. 2004 Mar 15;36(6):707-17
14990351
Nature. 1955 Aug 6;176(4475):250-4
13244669
Am J Physiol Heart Circ Physiol. 2004 Jul;287(1):H363-73
14975932
Basic Res Cardiol. 1984 Jan-Feb;79(1):49-58
6233965
BMJ. 1999 Sep 11;319(7211):703-4
10480833
Microvasc Res. 1978 Jan;15(1):93-101
634160
Am J Physiol. 1998 Dec;275(6):H2170-80
9843817
Am J Physiol. 1996 Mar;270(3 Pt 2):H827-36
8780176
Nat Methods. 2006 Nov;3(11):939-45
17060918
Am J Physiol Heart Circ Physiol. 2003 Oct;285(4):H1411-9
12805024
Am J Physiol. 1984 Apr;246(4 Pt 2):H508-17
6720909
Shock. 2005 Jul;24(1):66-73
15988323
Protein J. 2009 Jun;28(5):199-212
19653083
Exp Neurol. 1976 Feb;50(2):477-94
174928
Biophys Chem. 2001 Aug 30;92(1-2):103-17
11527583
J Lab Clin Med. 1999 Feb;133(2):112-9
9989762
Am J Physiol Heart Circ Physiol. 2005 Dec;289(6):H2392-400
16024576
Arch Biochem Biophys. 1977 Nov;184(1):222-36
21628
Res Exp Med (Berl). 1980;177(2):125-34
7003665
Nat Rev Drug Discov. 2005 Mar;4(3):221-35
15738978
Am J Physiol Heart Circ Physiol. 2004 Oct;287(4):H1609-17
15191899
J Biol Chem. 1998 May 15;273(20):12128-34
9575158
J Biochem. 1995 Dec;118(6):1151-60
8720129
Am J Physiol Heart Circ Physiol. 2002 Jul;283(1):H53-60
12063274
Adv Exp Med Biol. 1973;37A:277-92
4378058
Nat Med. 1997 Feb;3(2):177-82
9018236